Background {#Sec1}
==========

The detection and quantification of albumin in urine is common and important in clinical medical practice. It is widely used for screening of diabetic and hypertensive nephropathy, as well as preeclampsia. Microalbuminuria is also a risk factor for cardiovascular morbidity and mortality \[[@CR1]--[@CR5]\].

The urine sample used to measure albumin can be collected during a 24 h period, overnight (ON), or as a spot urine sample at any time of the day. It is still unclear how albumin excretion differs between 24 h and ON samples in a healthy population. The 24 h albumin excretion rate (AER, mg/h) is considered to be the gold standard, although the need for timed samples is still debated \[[@CR6]--[@CR8]\]. The simpler and therefore more widely used urinary albumin concentration (UAC, mg/L) can be adjusted for dilution, either using urinary creatinine (albumin to creatinine ratio, ACR, mg/g) or urine specific gravity (SG, albumin adjusted for specific gravity, ASG, mg/L).

There are many studies on urinary albumin (U-Alb) in diabetes and various other clinical conditions, but there is a notable lack of studies examining different ways of expressing albumin excretion in healthy individuals \[[@CR9], [@CR10]\]. Such information is important, for example, when urinary albumin is used in epidemiological studies searching for mild effects on renal function of nephrotoxic drugs or environmental contaminants, and in studies assessing associations between U-Alb and risk of cardiovascular disease.

This study had three aims:24 h sampling vs. overnight sampling: To examine associations and differences between U-Alb in 24 h and ON samples measured as AER, UAC, ACR, and ASG.Determinants in healthy subjects: To investigate how glomerular filtration rate (GFR), sex, age, body mass, smoking, and urinary flow (UF) affect U-Alb measured as AER, UAC, ACR, and ASG.Proxies: To investigate how well UAC, ACR, and ASG in ON samples reflect 24 h AER.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

Between 1999 and 2005, 152 healthy kidney donors (no kidney disease or diabetes, and normal GFR) were recruited and examined as previously described \[[@CR11], [@CR12]\]. Background data on these individuals are shown in Table [1](#Tab1){ref-type="table"}. Informed consent was obtained from the participants. The study adhered to the Declaration of Helsinki and was approved by the ethical review board of the University of Gothenburg.Table 1**Background data on participants and urine samples (means and ranges)**AllMenWomenN1526587Never-/ever-smokers (n)60/9127/3833/53Pack-years^a^13.8 (0.4-51.0)14.5 (0.4-51.0)13.3 (1.2-36.3)Body mass (lbs)165 (108--245)183 (143--245)150 (108--209)Age48 (24--70)49 (30--70)48 (24--64)GFR (ml/min/1.73 m^2^)101 (77.0-147)99.5 (78-140)101 (77.0-147)24 h samples (n)130557524 h collection time (hrs)23.2 (20.5-26.6)23.3 (21.5-26.6)23.1 (20.5-24.8)24 h volume (ml)1878 (444--5790)1795 (680--4199)1938 (444--5790)ON samples (n)1456382ON collection time (hrs)8.7 (6.0-14.8)8.7 (6.0-14.8)8.6 (6.3-11.3)ON volume (ml)419 (95--1050)434 (120-1050)407 (95--1002)^a^in ever-smokers.

Urine samples and biochemical assays {#Sec4}
------------------------------------

As previously described, two separate timed urine samples were collected from each of the participants on two consecutive days, one 24 h and one ON sample \[[@CR11], [@CR12]\]. In this collection, 123 participants provided both ON and 24 h samples, 22 provided only an ON sample, and 7 provided only a 24 h sample. Time since last urination (collection time) and sample volume were recorded (Table [1](#Tab1){ref-type="table"}).

Urinary albumin and creatinine concentrations were determined at the Department of Clinical Chemistry, Sahlgrenska University hospital, Gothenburg. Urinary albumin concentrations were determined on fresh samples by an automated nephelometric immunochemical method using reagents and calibrator from Beckman Coulter (Fullerton, CA, USA). Internal reference samples were used in each analytical run. The detection limit was 2.4 mg/L. Urinary creatinine concentrations were determined using the Jaffé method (Roche Diagnostics, GmbH, Mannheim, Germany) in the first three batches, and an enzymatic method (Modular P and CREAplus R1, R2, Roche/Hitachi, Roche Diagnostics, GmbH, Mannheim, Germany) in the last batch (N = 41). The methods are comparable \[[@CR13]\]. In addition, the laboratory performed internal quality control measures when introducing the enzymatic method, in order to ascertain that results were comparable. Specific gravity was measured with a refractometer (Medline, Ceti, Digit 012, Oxfordshire, UK).

GFR was measured using plasma clearance of iohexol or Cr-EDTA, except for a few cases where technetium-99 m-DTPA was used. The methods are comparable as GFR markers \[[@CR14]\].

AER, ACR, ASG, and UF were calculated from the UAC, sample volume, collection time, specific gravity, and creatinine concentration. ASG was adjusted to SG = 1.015 according to the formula ASG = U-Alb\*(1.015-1)/(specific gravity-1) \[[@CR15]\].

Statistics {#Sec5}
----------

UAC values below the detection limit (23 ON samples and 41 24 h samples) were replaced by detection limit/√2 = 2.4 /√2 = 1.7 \[[@CR16]\]. Statistical analyses were performed using version 9.2 of the SAS software package (SAS Institute, Cary, NC, USA). Several variables were not normally distributed. Associations between variables were tested with the Spearman correlation coefficient and with linear and multiple linear regression analysis. Differences between 24 h and ON samples were tested using paired t-tests. Differences between groups were tested using the Wilcoxon rank sum test. Statistical significance was determined at P\<0.05 (two-tailed). All multiple regression analyses were performed stepwise as shown below.

Results {#Sec6}
=======

Albumin excretion rate (AER) {#Sec7}
----------------------------

The 24 h albumin excretion rate was significantly *higher* than the ON AER (Table [2](#Tab2){ref-type="table"}). The association between 24 h and ON AER is shown in Figure [1](#Fig1){ref-type="fig"}.Table 2**Excretion rates and concentrations of albumin in 24 h and overnight (ON) samples**NMeanRangeP-value difference 24 h/overnightAlbumin excretion24 h AER (mg/24 h)1307.460.88-35.7\<0.001ON AER (mg/24 h)1455.850.81-29.6Albumin concentration24 h UAC (mg/L)1304.301.70-22.0\<0.001ON UAC (mg/L)1456.331.70-45.024 h ACR (mg/g Cr)1305.851.36-24.3\<0.001ON ACR (mg/g Cr)1454.940.83-24.924 h ASG (mg/L)1304.260.67-20.00.93ON ASG (mg/L)1454.460.98-27.3Creatinine concentration24 h UCC (g/L)1300.770.18-3.94\<0.001ON UCC (g/L)1451.280.33-2.49Specific gravity24 h SG1301.0160.005-1.038\<0.001ON SG1451.0211.006-1.040Urinary flow rate24 h UF (mL/h)13081.220.4-246\<0.001ON UF (mL/h)14549.211.5-150Creatinine excretion rate24 h CER (mg/24 h)13011.64.69-21.8\<0.001Overnight CER (mg/24 h)14511.03.07-19.6*Note:* Differences between 24 h and ON samples were calculated for 123 paired samples. *Abbreviations:* *AER* Albumin excretion rate, *UAC* Urinary albumin concentration, *ACR* Albumin to creatinine ratio, *Cr* Creatinine, *ASG* Albumin adjusted for specific gravity, *UCC* Urinary creatinine concentration, *SG* Specific gravity, *UF* Urinary flow.Figure 1**Association between albumin excretion rate in overnight and 24 h urine.** Association between albumin excretion rate (AER) in overnight (ON) and 24 h urine, both in mg/h. Regression line is shown: ON AER=0.075+0.50\*24 h AER. R^2^=0.62, P\<0.001. Hatched line: line of identity. *Note:* Conversion factor for AER in mg/h to mg/d, \*24.

There was a positive association between GFR and 24 h AER, but not between GFR and ON AER (Table [3](#Tab3){ref-type="table"}). There was a positive correlation between body mass and AER in both 24 h and ON samples. There was no significant correlation between UF and AER. Men had higher ON AER than women, but no significant difference was seen in 24 h AER (Table [4](#Tab4){ref-type="table"}). No difference was seen between never-smokers and ever-smokers.Table 3**Spearman correlation coefficients between 24 h AER, proxies and determinants**24 h AER24 h UAC24 h ACR24 h ASGON AERON UACON ACRON ASG24 h AER1.000.770.770.710.610.40^a^0.42^b^0.40\<0.001\<0.001\<0.001\<0.001\<0.001\<0.001\<0.00113013013013012312312312324 h UAC0.771.000.630.690.570.600.420.48\<0.001\<0.001\<0.001\<0.001\<0.001\<0.001\<0.00113013013013012312312312324 h ACR0.770.631.000.750.440.310.670.41\<0.001\<0.001\<0.001\<0.001.0005\<0.001\<0.00113013013013012312312312324 h ASG0.710.690.751.000.500.400.540.59\<0.001\<0.001\<0.001\<0.0010.005\<0.001\<0.001130130130130123123123123GFR0.240.210.180.080.050.070.040.060.0060.020.040.350.580.390.670.49130130130130144144144144Sex-0.12-0.170.330.07-0.28-0.090.210.080.160.06\<0.0010.400.0070.260.010.92130130130130145145145145Body mass0.170.21-0.220.030.300.11-0.140.090.040.020.010.79\<0.0010.210.050.34128128128128142142142142Smoking-0.04-0.090.01-0.15-0.03-0.080.05-0.020.610.330.880.090.720.340.520.83129129129129144144144144Age-0.080.060.06-0.020.130.090.230.090.380.500.530.830.120.300.0060.27130130130130145145145145UF0.06^c^-0.51^c^-0.006^c^-0.11^c^-0.03^d^-0.70^d^-0.18^d^-0.41^d^0.47\<0.0010.940.210.68\<0.0010.04\<0.001130130130130145145145145UCC0.1^e^0.54^e^-0.24^e^0.05^e^0.24^f^0.71^f^-0.06^f^0.35^f^0.10\<0.0010.0050.560.04\<0.0010.94\<0.001130130130130145145145145*Note:* First row in each cell, spearman correlation coefficient; second row, P-value; third row, number of observations.*Abbreviations:* *ON* Overnight, *AER* Albumin excretion rate, *UAC* Urinary albumin concentration, *ASG* Albumin adjusted for specific gravity, *ACR* Albumin to creatinine ratio, *GFR* Glomerular filtration rate, *UF* Urinary flow, *UCC* Urinary creatinine concentration.^a^Men: r=0.59, P\<0.001, N=53; Women: r=0.24, P=0.043, N=70. ^b^Men: r=0.64, P\<0.001, N=53; Women: r=0.37, P=0.002, N=70. ^c^24 h UF. ^d^ON UF. ^e^24 h UCC. ^f^ON UCC.Table 4**Differences between men and women and between ever-smokers and never-smokers**WomenMenEver-smokersNever-smokersMeanMeanP^a^MeanMeanP^a^24 h AER (mg/24 h)6.958.160.167.057.990.61ON AER (mg/24 h)5.596.19\<0.0015.476.500.7124 h UAC (mg/L)3.934.800.063.914.900.33ON UAC (mg/L)6.516.100.265.697.420.3424 h ACR (mg/g Cr)6.375.130.0015.815.840.09ON ACR (mg/g Cr)5.554.150.0044.735.290.5224 H ASG mg/L)4.334.150.404.004.660.16ON ASG (mg/L)4.814.010.924.184.960.8324 h UCC (g/L)0.610.99\<0.0011.200.870.03ON UCC (g/L)1.121.49\<0.0011.021.420.0424 h SG1.0141.018\<0.0011.0161.0160.96ON SG1.0191.0230.0081.0201.0220.12*Abbreviations:* *ON* Overnight, *AER* Albumin excretion rate, *UAC* Urinary albumin concentration, *ASG* Albumin adjusted for specific gravity, *ACR* Albumin to creatinine ratio, *Cr* Creatinine, *GFR* Glomerular filtration rate, *UCC* Urinary creatinine concentration, *SG* Specific gravity.^a^Wilcoxon rank sum test.

In a multiple regression analysis according to Equation [1](#Equ1){ref-type=""} the positive association between GFR and the 24 h AER remained (P = 0.003) but there was no significant association with ON AER (P = 0.09). Body mass was associated with ON AER (P = 0.02), but not with 24 h AER (P = 0.06).

Urinary albumin concentration (UAC) {#Sec8}
-----------------------------------

As expected, the 24 h UAC was significantly *lower* than UAC in the more concentrated ON samples (Table [2](#Tab2){ref-type="table"}). The association between ON and 24 h UAC is shown in Figure [2](#Fig2){ref-type="fig"} and the association between ON UAC and 24 h AER in Figure [3](#Fig3){ref-type="fig"}.Figure 2**Association between urinary albumin concentration in overnight and 24 h urine.** Association between urinary albumin concentration (UAC) in overnight (ON) and 24 h urine, both in mg/L. Regression line is shown: ON UAC=0.73+0.62\*24 h UAC. R^2^=0.46, P\<0.001. Hatched line: line of identity. *Note:* Conversion factor for UAC in mg/L to g/dL, \*10^-4^.Figure 3**Association between overnight urinary albumin concentration and 24 h albumin excretion rate.** Association between overnight urinary albumin concentration (ON UAC) and 24 h albumin excretion rate (24 h AER). Regression line is shown: ON UAC=2.47+10.8\*24 h AER. R^2^=0.38, P\<0.001. *Note:* Conversion factor for UAC in mg/L to g/dL, \*10^-4^. Conversion factor for AER in mg/h to mg/d, \*24.

Again as expected, both ON and 24 h UAC showed significant negative correlations with UF (Table [3](#Tab3){ref-type="table"}). The 24 h UAC was positively associated with GFR and body mass, while this was not the case for ON UAC. Men tended to have higher 24 h UAC than women (P = 0.06), but no difference was seen in ON UAC (Table [4](#Tab4){ref-type="table"}). No difference was seen between never-smokers and ever-smokers.

A multiple regression analysis according to Equation [1](#Equ1){ref-type=""} showed a significant negative association between UAC and UF in 24 h (P = 0.002) and ON (P\<0.001) samples. There were also positive associations with GFR (P = 0.005) for 24 h UAC, but not significantly so for ON UAC (P = 0.08). Ever-smokers had higher 24 h UAC (P = 0.049) than never-smokers. There was no significant impact of age, sex, or body mass.

Albumin to creatinine concentration (ACR) {#Sec9}
-----------------------------------------

The 24 h ACR was significantly higher than ON ACR (Table [2](#Tab2){ref-type="table"}; regression equation: ON ACR = 0.15+0.58\*24). The association between ON ACR and 24 h AER is shown in Figure [4](#Fig4){ref-type="fig"}. The 24 h ACR but not the ON ACR was negatively correlated with the urinary creatinine concentration (Table [3](#Tab3){ref-type="table"}). The 24 h ACR was positively correlated with GFR and negatively correlated with body mass. The ON ACR was positively correlated with age and negatively correlated with body mass. Both 24 h and ON ACR were higher in women than in men (Table [4](#Tab4){ref-type="table"}). No significant difference was seen between never-smokers and ever-smokers.Figure 4**Association between overnight urinary albumin to creatinine ratio and 24 h albumin excretion rate.** Association between overnight urinary albumin to creatinine ratio (ON ACR) and 24 h albumin excretion rate (24 h AER). Regression line is shown: ON ACR=0.23+0.96\*24 h AER. R^2^=0.44, P\<0.001. *Note:* Conversion factor for ACR in mg/mmol to mg/g, \*8.84. Conversion factor for AER in mg/h to mg/d, \*24.

In a multiple regression analysis according to Equation [1](#Equ1){ref-type=""}, the associations with sex (higher in women; 24 h ACR: P = 0.03; ON ACR P = 0.02) and GFR (24 h ACR: P = 0.001; ON ACR P = 0.04) remained, while there was no significant impact of age, body mass, or smoking. ON UF was not significantly associated with ON ACR (P = 0.09).

Albumin adjusted for specific gravity (ASG) {#Sec10}
-------------------------------------------

The 24 h and ON ASG were not significantly different (Table [2](#Tab2){ref-type="table"}). The associations between 24 h and ON ASG on the one hand and the 24 h AER on the other were similar to those for the corresponding UAC and ACR measures (Table [3](#Tab3){ref-type="table"}). No significant difference was seen between men and women or between never-smokers and ever-smokers (Table [4](#Tab4){ref-type="table"}).

A multiple regression analysis according to Equation [1](#Equ1){ref-type=""} showed a positive association between GFR and 24 h ASG (P = 0.03). ON ASG was negatively associated with UF (P = 0.01).

Discussion {#Sec11}
==========

The present study showed that AER was higher in 24 h than in ON samples. ON samples may thus cause an underestimation (about 25%) of the true albumin excretion (Table [3](#Tab3){ref-type="table"} and Figure [1](#Fig1){ref-type="fig"}). To our knowledge, only two previous studies have examined diurnal variation of albumin excretion in healthy subjects, both showing lower excretion in ON samples \[[@CR17], [@CR18]\]. The reason for this difference may include daytime erect position (postural proteinuria) or physical exercise \[[@CR18]--[@CR21]\]. However, Montagna et al. also found a variation independent of posture and activity \[[@CR18]\], which may be explained by diurnal variation of GFR secondary to diurnal variation in blood pressure \[[@CR22], [@CR23]\].

We also found that 24 h AER was significantly positively correlated with GFR, and there was a similar tendency for ON AER. This finding is in agreement with rat experiments by Ohlson et al. \[[@CR24]\] Some authors have, however, found that the glomerular filtration of albumin is relatively independent of GFR, while the urinary excretion of albumin is more dependent on possible saturation of tubular reabsorption \[[@CR25]\]. An explanation of the different results could be that we studied inter-individual variation in GFR while Smithies discussed intra-individual variation \[[@CR25]\].

AER was associated with body mass, in agreement with previous studies showing an association between 24 h AER and BMI \[[@CR5], [@CR26]\].

We found no significant association between AER and UF. However, it has been shown that water loading does increase AER, perhaps because the reuptake mechanisms are less effective, or possibly because of increased GFR due to increased blood pressure \[[@CR27]\]. Our findings suggest that this does not occur during physiological variations in UF.

The 24 h AER was not significantly different in women and men, while the ON AER was slightly higher in men. The explanation may be the higher body mass in men, since in the multiple regression model body mass, but not sex, had a significant impact on AER.

There was no difference in AER between never-smokers and ever-smokers, a finding in line with previous inconclusive studies \[[@CR28]\]. We found no significant correlation between AER and age, in agreement with most previous studies \[[@CR28], [@CR29]\].

The ON UAC was higher than 24 h UAC, despite the fact that the AER was lower in ON than 24 h samples. The difference between ON and 24 h UAC samples must therefore have been caused by dilution (higher UF; see Table [2](#Tab2){ref-type="table"}). UAC was significantly positively correlated with GFR in a multiple regression analysis, as was AER.

The association between ON UAC and 24 h AER was only moderate (R^2^ = 0.38, Figure [3](#Fig3){ref-type="fig"}), although the correlation was not much lower than for ON ACR and ON ASG (Table [3](#Tab3){ref-type="table"}). This indicates that creatinine adjustment may not be necessary if ON samples are used. ON UAC has been suggested to replace ACR as screening method \[[@CR30]--[@CR35]\]. The situation is different in daytime spot samples, which may be much diluted.

The 24 h ACR was higher than ON ACR, reflecting the corresponding difference seen for AER. ACR was significantly positively correlated with GFR in a multiple regression analysis, as was AER.

Random spot ACR have been used and there is evidence that they can adequately predict 24 h urinary protein loss in diabetics and others with kidney disease \[[@CR9]\]. However, there are no studies known to us that shows this in healthy individuals. Previous studies have shown that U-Alb varies not only between day and night, but during the day as well, and this variability must be taken into consideration when interpreting the results \[[@CR9], [@CR36]\]. Overnight samples have a longer collection period than day-time spot samples, and physical activity, posture and intake of fluids varies less during the night than in the day. Therefore we believe that ON samples are to prefer over random day-time samples when evaluating U-Alb. As expected, there was a significant difference in concentrations and excretion rates of creatinine (data not shown) and ACR between men and women. This is known to be caused by higher muscle mass in men \[[@CR37]--[@CR39]\]. Although ON UF was positively correlated with ON creatinine excretion rate, UF did not have any impact on ACR. ON ACR was the only albumin measure we found to correlate with age \[[@CR40], [@CR41]\], probably due to lower muscle mass at higher age.

ON ACR, which is widely used for screening purposes, showed a somewhat higher correlation with 24 h AER (R^2^ = 0.44) than did ON UAC. ON ACR is relatively easy to collect and measure, which makes it suitable to use for screening and follow up in individual patients \[[@CR6], [@CR42]--[@CR44]\]. Lambers Heerspink et al. showed that first morning ACR was just as good as 24 h AER for prediction of cardiovascular disease \[[@CR42]\], and suggested that this may be due to many errors in collection of 24 h samples. However, ACR may generate some falsely high ACR levels in patients with low muscle mass and hence low creatinine excretion \[[@CR37]\]. ACR is a well-established measure, but has not been studied in all populations, and most of the available data are on diabetics.

There was no difference between 24 h and ON ASG, probably because ON SG was significantly higher than 24 h SG (Table [2](#Tab2){ref-type="table"}). Thus, adjusting for SG did not capture the true difference between ON and 24 h AER.

ASG is sensitive to hematuria and glucosuria, since they affect specific gravity \[[@CR45], [@CR46]\]. On the other hand, we found little or no correlation between ASG and other variables in this study, such as age, sex, and body mass.

Although its routine use is rare, ASG could be used instead of ACR, especially in situations where creatinine excretion varies due to factors such as changes in body composition and protein intake \[[@CR47]\]. However, SG may be affected by intake of certain food, like salt. Elkins et al. also found that creatinine adjustment is more suitable for very diluted or concentrated samples \[[@CR46]\].

A strength of this study is the fact that separate ON and 24 hour samples were collected; that is, the ON sample was not included in the 24 hour sample \[[@CR10]\]. U-Alb is known to have intra-individual variation of 44-85 % (between days), depending on sample types \[[@CR40], [@CR48]--[@CR50]\]. Despite this variability, we could show a difference between ON and 24 h samples collected on separate days. If the ON sample had been a part of the 24 h sample, we would have had better power to quantify differences between ON and 24 h samples.

The samples were collected when the study subjects were hospitalized, which reduced the risk of contamination and collection errors. It is often recommended that very concentrated (U-Crea\>3 g/L) or dilute (U-Crea\<0.3 g/L) samples should be excluded, since the validity of such samples could be questioned. However, in the present study, such urine samples were included, since one of the aims was to study the impact of UF on albumin excretion.

The albumin concentrations were analyzed in fresh urine samples. It has been shown that freezing and thawing of urine can underestimate and increase the variability of measured U-Alb.

Another strength is the fact that we had data on measured GFR. To the best of our knowledge, associations between GFR and U-Alb in healthy subjects have not been reported previously. Estimated GFR (eGFR) is widely used, and there are several different equations to obtain this measure. It is however important to remember that while it is useful for population studies, eGFR is a blunt tool for use in individual patients.

A limitation is the fact that the study was performed on kidney donors, who are somewhat 'more healthy' that a general population sample. People with diabetes, hypertension, or kidney disease were not included in our sample. On the other hand, as shown in Table [1](#Tab1){ref-type="table"}, our sample was diverse enough to include a person of 70 years of age and a long-term heavy smoker.

Conclusions {#Sec12}
===========

The 24 h AER is the gold standard, even though other measures of U-Alb may work relatively well. ON AER will underestimate the 24-hour albumin excretion, probably due to nocturnal hypotension and subsequent reduction of glomerular filtration pressure. In addition, GFR and body mass are positively associated with AER and ACR. The differences between the various estimates of albumin excretion are large enough to be worth considering in scientific studies in healthy adults.
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